Panacea-Sanofi settle first of its kind patent infringement case
Panacea has agreed to forego its claim for damages and rendition of accounts in the proceedings against Sanofi as prayed in the suit it had filed in the Delhi High Court.
Panacea has agreed to forego its claim for damages and rendition of accounts in the proceedings against Sanofi as prayed in the suit it had filed in the Delhi High Court.
Natco Pharma plans to launch its CTPR products very shortly, which is estimated to have a market size of over ₹2,000 crore in India.